Concord Medical Services Holdings (FRA:C2C) Piotroski F-Score: 6 (As of Jul. 05, 2026) — 50% Above Median


FRA:C2C Concord Medical Services Holdings Ltd FRA:C2C
51 GF Score
Price €6.25
GF Value €9.81
! 6 Warning Signs
View Full Analysis

What is Concord Medical Services Holdings Piotroski F-Score?

Concord Medical Services Holdings FRA:C2C 51 Piotroski F-Score is 6 as of Jul. 05, 2026, which is 50% above its 10-year median of 4.00. GuruFocus rates FRA:C2C with a GF Score™ of 51/100 and a GF Value™ of €9.81. The stock has 6 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Concord Medical Services Holdings ranks better than 74.65% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Concord Medical Services Holdings has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Concord Medical Services Holdings's Piotroski F-Score or its related term are showing as below:

FRA:C2C' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 6

During the past 13 years, the highest Piotroski F-Score of Concord Medical Services Holdings was 6. The lowest was 1. And the median was 4.

Concord Medical Services Holdings  (FRA:C2C) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Concord Medical Services Holdings Piotroski F-Score Related Terms


Concord Medical Services Holdings Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Concord Medical Services Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Services Holdings Piotroski F-Score Chart

Concord Medical Services Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 6.00 2.00 6.00

Concord Medical Services Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 2.00 0.00 6.00

FRA:C2C vs CCEL, GBCS, CDIX: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's Piotroski F-Score falls into.


FRA:C2C
51GF Score
Concord Medical Services Holdings Ltd FRA:C2C
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was €-11.25 Mil.
Cash Flow from Operations was €-24.47 Mil.
Revenue was €55.84 Mil.
Gross Profit was €3.13 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (882.292 + 793.879) / 2 = €838.0855 Mil.
Total Assets at the begining of this year (Dec24) was €882.29 Mil.
Long-Term Debt & Capital Lease Obligation was €316.71 Mil.
Total Current Assets was €114.21 Mil.
Total Current Liabilities was €236.98 Mil.
Net Income was €-40.43 Mil.

Revenue was €50.36 Mil.
Gross Profit was €-10.38 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (777.494 + 882.292) / 2 = €829.893 Mil.
Total Assets at the begining of last year (Dec23) was €777.49 Mil.
Long-Term Debt & Capital Lease Obligation was €374.17 Mil.
Total Current Assets was €129.07 Mil.
Total Current Liabilities was €278.78 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Concord Medical Services Holdings's current Net Income (TTM) was -11.25. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Concord Medical Services Holdings's current Cash Flow from Operations (TTM) was -24.47. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=-11.253/882.292
=-0.01275428

ROA (Last Year)=Net Income/Total Assets (Dec23)
=-40.432/777.494
=-0.05200297

Concord Medical Services Holdings's return on assets of this year was -0.01275428. Concord Medical Services Holdings's return on assets of last year was -0.05200297. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Concord Medical Services Holdings's current Net Income (TTM) was -11.25. Concord Medical Services Holdings's current Cash Flow from Operations (TTM) was -24.47. ==> -24.47 <= -11.25 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=316.71/838.0855
=0.377897

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=374.17/829.893
=0.45086535

Concord Medical Services Holdings's gearing of this year was 0.377897. Concord Medical Services Holdings's gearing of last year was 0.45086535. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=114.209/236.976
=0.48194332

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=129.066/278.78
=0.46296721

Concord Medical Services Holdings's current ratio of this year was 0.48194332. Concord Medical Services Holdings's current ratio of last year was 0.46296721. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Concord Medical Services Holdings's number of shares in issue this year was 4.368. Concord Medical Services Holdings's number of shares in issue last year was 4.368. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=3.131/55.838
=0.05607293

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-10.384/50.363
=-0.20618311

Concord Medical Services Holdings's gross margin of this year was 0.05607293. Concord Medical Services Holdings's gross margin of last year was -0.20618311. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=55.838/882.292
=0.06328744

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=50.363/777.494
=0.06477606

Concord Medical Services Holdings's asset turnover of this year was 0.06328744. Concord Medical Services Holdings's asset turnover of last year was 0.06477606. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+1+1+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Concord Medical Services Holdings has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Concord Medical Services Holdings (FRA:C2C) has a Piotroski F-Score of 6 as of Jul. 05, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Concord Medical Services Holdings and its competitors. This is 50% above median its historical median of 4.00. Over the past decade, Concord Medical Services Holdings' Piotroski F-Score has ranged from 1.00 to 6.00. According to the industry distribution chart, Concord Medical Services Holdings ranks #165 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 25.3%.
Is Concord Medical Services Holdings' Piotroski F-Score too high?
Concord Medical Services Holdings' current Piotroski F-Score of 6 is 50% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 6.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Concord Medical Services Holdings' value of 6 is 20% above this industry median. Based on the distribution chart, Concord Medical Services Holdings ranks #165 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Concord Medical Services Holdings has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' Piotroski F-Score compare to CCEL and GBCS?
According to the Healthcare Providers & Services industry distribution chart, Concord Medical Services Holdings ranks #165 out of 651 companies for Piotroski F-Score. This puts Concord Medical Services Holdings in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Concord Medical Services Holdings' value of 6 is 20% above this benchmark. Historically, Concord Medical Services Holdings' own Piotroski F-Score has ranged from 1.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Concord Medical Services Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Concord Medical Services Holdings's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Concord Medical Services Holdings and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Medical Services Holdings's current Piotroski F-Score is 6, which is 50% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current Piotroski F-Score of 6. The stock's GF Value™ is €9.81, compared to a current price of €6.25 — trading 36.3% below its estimated fair value. The current Piotroski F-Score is 6, which is 50% above median its 10-year median of 4.00 and 20% above the Healthcare Providers & Services industry median of 5.00. Concord Medical Services Holdings' overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current Piotroski F-Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued. The current stock price of €6.25 is trading 36.3% below its estimated GF Value™ of €9.81.

Key valuation signals for FRA:C2C:

  • Piotroski F-Score: 6 (50% above median its 10-year median of 4.00)
  • GF Value™: €9.81 vs. price of €6.25 (36.3% below fair value)
  • GF Score™: 51/100 with 6 warning signs
  • Industry Position: 20% above the Healthcare Providers & Services median (#165 of 651)

No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Concord Medical Services Holdings Business Description

Other Exchanges CCM:USA
Address Hanwei Plaza Building, No. 7 Guanghua Road, Room A1-A5, 26th Floor, East Area, Chaoyang District, Beijing, CHN, 100020
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
51GF Score

Get the complete analysis for FRA:C2C

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.25
Price
€9.81
GF Value